Evaluation of leishmaniasis wound healing in topical treatment with 5% thyme gel versus intra lesional(IL) Glucantime treatment

Phase 3

• Conditions: lesion of cutaneous Leishmaniasis.; Cutaneous leishmaniasis; B55.1

• Registration Number: IRCT20211211053349N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients must be 5 years old or older.
The patient can be of both sexes.
The number of wounds should not be more than 5.
No sores on the face or ears.
Affirmation of parasitic infection is required
The patient has cutaneous leishmaniasis.
The onset of their disease is less than 4 months

Exclusion Criteria

Pregnant women are excluded from the study.
Patients with severe hypoglycemia are excluded from the study.
Breastfeeding women are excluded from the study.
Patients who have been treated with other methods (systemic Glucantime, combination therapy, etc.)
patients who have been treated in other clinical trial

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Wound healing. Timepoint: lesion diameter. Method of measurement: recurence.